POTASSIUM BROMIDE

POTASSIUM BROMIDE was reported 532 times

POTASSIUM BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BROMODERMA 5 0.5000
1 DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY WITH SPIKE-AND-WAVE ACTIVATION IN SLEEP 1 0.5000
2 NEUROGENIC PULMONARY OEDEMA 2 0.2000
3 BLOOD GLUCOSE FALSE POSITIVE 4 0.0833
4 HEMICLONIC SEIZURE 1 0.0667
5 INFANT SEDATION 2 0.0606
6 ANTACID THERAPY 7 0.0538
7 CONGENITAL HIATUS HERNIA 12 0.0526
8 SLEEP DISORDER THERAPY 8 0.0404
9 PAROXYSMAL SYMPATHETIC HYPERACTIVITY 3 0.0400
10 COAGULATION FACTOR V LEVEL INCREASED 1 0.0385
11 MALIGNANT MELANOMA STAGE 0 8 0.0383
12 FOREIGN BODY EMBOLISM 1 0.0312
13 SPASTIC PARAPLEGIA 1 0.0286
14 ANALGESIC THERAPY 8 0.0249
15 ANTICOAGULANT THERAPY 7 0.0246
16 DRUG THERAPY 8 0.0236
17 BLOOD KETONE BODY DECREASED 1 0.0213
18 METAPNEUMOVIRUS PNEUMONIA 2 0.0208
19 GAUCHER'S DISEASE 1 0.0182
20 APPENDICOLITH 7 0.0181
21 ARTHROPOD INFESTATION 1 0.0135
22 PATIENT RESTRAINT 1 0.0130
23 CARNITINE DECREASED 1 0.0122
24 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 8 0.0086
25 ASTEATOSIS 1 0.0085
26 HYPERDYNAMIC LEFT VENTRICLE 2 0.0081
27 BACTEROIDES INFECTION 2 0.0077
28 MULTIPLE-DRUG RESISTANCE 22 0.0071
29 CLONIC CONVULSION 5 0.0068
30 MYOCLONIC EPILEPSY 10 0.0066
31 HISTONE ANTIBODY POSITIVE 1 0.0064
32 ATONIC SEIZURES 5 0.0058
33 NEAR DROWNING 1 0.0057
34 HYPERPHOSPHATAEMIA 11 0.0051
35 DROP ATTACKS 3 0.0051
36 IRREGULAR SLEEP WAKE RHYTHM DISORDER 1 0.0050
37 SEIZURE CLUSTER 4 0.0048
38 OPSOCLONUS MYOCLONUS 1 0.0047
39 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
40 EPILEPTIC ENCEPHALOPATHY 1 0.0045
41 INFANTILE SPASMS 3 0.0041
42 PROTEIN-LOSING GASTROENTEROPATHY 2 0.0040
43 PETIT MAL EPILEPSY 18 0.0035
44 SELF-DESTRUCTIVE BEHAVIOUR 3 0.0034
45 MITRAL VALVE THICKENING 1 0.0034
46 VAGAL NERVE STIMULATOR IMPLANTATION 1 0.0033
47 STATUS EPILEPTICUS 34 0.0030
48 LARYNGOMALACIA 1 0.0030
49 PLEURITIC PAIN 8 0.0029
50 FANCONI SYNDROME 4 0.0028
51 RESPIRATORY SYMPTOM 8 0.0028
52 SALIVARY GLAND CALCULUS 1 0.0027
53 BLOOD PHOSPHORUS INCREASED 7 0.0026
54 UPPER RESPIRATORY TRACT INFLAMMATION 3 0.0025
55 HYPERAMMONAEMIA 12 0.0024
56 HYPERKINESIA 5 0.0024
57 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 11 0.0022
58 BLOOD IRON INCREASED 4 0.0021
59 TONIC CONVULSION 3 0.0021
60 HYPERCALCIURIA 1 0.0020
61 BLOOD IMMUNOGLOBULIN M DECREASED 2 0.0020
62 HYPOHIDROSIS 1 0.0020
63 HYPERCREATININAEMIA 1 0.0020
64 PSYCHOTIC BEHAVIOUR 2 0.0020
65 DRUG LEVEL ABNORMAL 1 0.0019
66 TOTAL LUNG CAPACITY DECREASED 3 0.0019
67 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 1 0.0019
68 BLOOD MAGNESIUM ABNORMAL 1 0.0018
69 COMPLEX PARTIAL SEIZURES 2 0.0018
70 DEVICE MAINTENANCE ISSUE 1 0.0017
71 DERMATILLOMANIA 1 0.0017
72 BRAIN HERNIATION 5 0.0017
73 FEBRILE CONVULSION 2 0.0016
74 HYPOPHOSPHATAEMIA 12 0.0016
75 BREATH SOUNDS ABNORMAL 8 0.0016
76 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
77 BODY HEIGHT BELOW NORMAL 1 0.0016
78 IRON DEFICIENCY 7 0.0016
79 DEVELOPMENTAL DELAY 14 0.0016
80 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
81 CHANGE IN SEIZURE PRESENTATION 1 0.0015
82 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
83 PHYSICAL ASSAULT 3 0.0014
84 ATAXIA 17 0.0014
85 INFUSION SITE INFLAMMATION 1 0.0014
86 PCO2 INCREASED 1 0.0014
87 ORTHOSTATIC INTOLERANCE 1 0.0014
88 MYASTHENIA GRAVIS 11 0.0014
89 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
90 INTELLECTUAL DISABILITY 2 0.0013
91 CALCULUS URINARY 2 0.0013
92 LYMPHOCYTE STIMULATION TEST POSITIVE 1 0.0012
93 BLOOD URIC ACID INCREASED 7 0.0012
94 PRESCRIBED UNDERDOSE 24 0.0012
95 CRANIOFACIAL FRACTURE 1 0.0012
96 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
97 LUNG OPACITY 3 0.0011
98 ABULIA 1 0.0011
99 CEREBRAL PALSY 1 0.0011
100 ATRIOVENTRICULAR BLOCK 8 0.0010
101 EYE MOVEMENT DISORDER 7 0.0010
102 SPUTUM RETENTION 1 0.0010
103 QUADRIPLEGIA 2 0.0010
104 PERTUSSIS 1 0.0010
105 RESPIRATORY TRACT IRRITATION 1 0.0010
106 TEETH BRITTLE 1 0.0010
107 ASTERIXIS 1 0.0009
108 TROPONIN INCREASED 7 0.0009
109 BLADDER DILATATION 1 0.0009
110 EPILEPSY 27 0.0009
111 AORTIC STENOSIS 3 0.0009
112 ASPIRATION 9 0.0008
113 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
114 BLADDER DISCOMFORT 1 0.0008
115 BLOOD CALCIUM INCREASED 7 0.0008
116 HYPERTHERMIA 6 0.0008
117 TONIC CLONIC MOVEMENTS 1 0.0008
118 FULL BLOOD COUNT ABNORMAL 8 0.0008
119 APPENDICITIS 7 0.0007
120 BEHAVIOUR DISORDER 4 0.0007
121 SIALOADENITIS 1 0.0007
122 HYPERCHOLESTEROLAEMIA 7 0.0007
123 VENTRICULAR FIBRILLATION 8 0.0007
124 ANTICONVULSANT DRUG LEVEL DECREASED 1 0.0007
125 CATAPLEXY 1 0.0007
126 MICTURITION URGENCY 8 0.0007
127 TRACHEOSTOMY 1 0.0007
128 NOROVIRUS INFECTION 1 0.0007
129 DRUG LEVEL DECREASED 7 0.0007
130 SLEEP PARALYSIS 1 0.0007
131 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
132 IMPETIGO 1 0.0007
133 ENCEPHALOPATHY 16 0.0007
134 ORAL MUCOSAL ERYTHEMA 1 0.0006
135 GASTROSTOMY 1 0.0006
136 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 11 0.0006
137 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
138 SKULL FRACTURE 1 0.0006
139 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
140 PANCREATIC DISORDER 3 0.0006
141 BACTERIAL INFECTION 11 0.0006
142 AMMONIA INCREASED 3 0.0006
143 HYPERLIPIDAEMIA 7 0.0006
144 APLASTIC ANAEMIA 3 0.0006
145 INFUSION SITE DISCHARGE 1 0.0006
146 ALOPECIA AREATA 1 0.0006
147 MITRAL VALVE DISEASE 1 0.0006
148 CARDIOGENIC SHOCK 8 0.0006
149 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
150 NEURALGIA 13 0.0005
151 MITRAL VALVE INCOMPETENCE 6 0.0005
152 RALES 3 0.0005
153 PYELONEPHRITIS ACUTE 1 0.0005
154 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
155 TRICUSPID VALVE INCOMPETENCE 4 0.0005
156 BLOOD TEST ABNORMAL 7 0.0005
157 CHOLANGITIS 3 0.0005
158 BRAIN OEDEMA 6 0.0005
159 SCREAMING 3 0.0005
160 SPUTUM INCREASED 1 0.0005
161 MULTIPLE ORGAN DYSFUNCTION SYNDROME 13 0.0005
162 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
163 RHINITIS ALLERGIC 2 0.0004
164 BRONCHIECTASIS 3 0.0004
165 ULCER 7 0.0004
166 HAEMOGLOBIN INCREASED 2 0.0004
167 DRUG LEVEL INCREASED 7 0.0004
168 WEIGHT ABNORMAL 1 0.0004
169 ACUTE PSYCHOSIS 1 0.0004
170 DEVICE INFUSION ISSUE 1 0.0004
171 INFREQUENT BOWEL MOVEMENTS 1 0.0004
172 HYPOTONIA 4 0.0004
173 GOUT 7 0.0004
174 END STAGE RENAL DISEASE 7 0.0004
175 PARTIAL SEIZURES 2 0.0004
176 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
177 JOINT INJURY 8 0.0004
178 BLOOD SODIUM INCREASED 1 0.0004
179 SLEEP DISORDER 26 0.0004
180 SEIZURE 42 0.0004
181 HYPERKERATOSIS 2 0.0004
182 CEREBRAL THROMBOSIS 1 0.0004
183 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
184 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
185 HEPATITIS FULMINANT 1 0.0003
186 BLOOD CULTURE POSITIVE 1 0.0003
187 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
188 HYPERCAPNIA 1 0.0003
189 NASAL DRYNESS 2 0.0003
190 RESPIRATORY RATE DECREASED 1 0.0003
191 SPUTUM DISCOLOURED 3 0.0003
192 CARDIOVASCULAR DISORDER 8 0.0003
193 TRANSAMINASES INCREASED 7 0.0003
194 MYDRIASIS 4 0.0003
195 OTITIS MEDIA 1 0.0003
196 SOMNOLENCE 59 0.0003
197 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
198 HYPOPNOEA 1 0.0003
199 HANGOVER 1 0.0003
200 CONJUNCTIVAL HYPERAEMIA 1 0.0003
201 TONGUE DISORDER 2 0.0003
202 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
203 IMPULSIVE BEHAVIOUR 1 0.0003
204 CATHETER SITE INFECTION 1 0.0003
205 CORONARY ARTERY DISEASE 8 0.0003
206 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
207 HYPONATRAEMIA 14 0.0002
208 PNEUMONIA ASPIRATION 6 0.0002
209 AGGRESSION 12 0.0002
210 ASCITES 7 0.0002
211 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
212 EATING DISORDER 5 0.0002
213 BLOOD MAGNESIUM DECREASED 2 0.0002
214 BLOOD CREATINE INCREASED 1 0.0002
215 CARDIOTOXICITY 2 0.0002
216 SUBCUTANEOUS ABSCESS 1 0.0002
217 AFFECT LABILITY 2 0.0002
218 RENAL CELL CARCINOMA 1 0.0002
219 LIVER DISORDER 9 0.0002
220 PULMONARY MASS 3 0.0002
221 HEPATIC ENZYME ABNORMAL 1 0.0002
222 TOXIC ENCEPHALOPATHY 1 0.0002
223 PATHOLOGICAL FRACTURE 1 0.0002
224 FAILURE TO THRIVE 1 0.0002
225 THERAPY PARTIAL RESPONDER 3 0.0002
226 SERUM FERRITIN INCREASED 1 0.0002
227 NYSTAGMUS 1 0.0002
228 LIVER FUNCTION TEST INCREASED 4 0.0002
229 STRESS FRACTURE 1 0.0002
230 PROSTATIC DISORDER 1 0.0002
231 DENTAL CARIES 2 0.0002
232 CARDIAC VALVE DISEASE 1 0.0002
233 HYPERTONIA 1 0.0002
234 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
235 HYPOXIA 6 0.0002
236 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
237 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
238 SCOLIOSIS 1 0.0002
239 OLIGURIA 1 0.0002
240 DRUG-INDUCED LIVER INJURY 5 0.0002
241 BLEPHAROSPASM 1 0.0002
242 HYPOPHAGIA 4 0.0002
243 PULMONARY FIBROSIS 3 0.0002
244 CHOLESTASIS 3 0.0002
245 PRESCRIBED OVERDOSE 3 0.0002
246 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
247 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
248 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
249 BLOOD CHOLESTEROL INCREASED 7 0.0002
250 DIABETES MELLITUS 11 0.0001
251 LUNG DISORDER 7 0.0001
252 GENERAL PHYSICAL HEALTH DETERIORATION 16 0.0001
253 FAECES SOFT 1 0.0001
254 APATHY 2 0.0001
255 THROMBOSIS 11 0.0001
256 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
257 THYROID DISORDER 2 0.0001
258 SWELLING 12 0.0001
259 AFFECTIVE DISORDER 1 0.0001
260 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
261 ABNORMAL BEHAVIOUR 5 0.0001
262 DRUG INTERACTION 20 0.0001
263 BLOOD ALBUMIN DECREASED 1 0.0001
264 INTENTIONAL PRODUCT MISUSE 11 0.0001
265 SEPSIS 14 0.0001
266 ABSCESS 2 0.0001
267 MUSCLE DISORDER 1 0.0001
268 RESPIRATORY FAILURE 9 0.0001
269 HEMIPLEGIA 1 0.0001
270 INFUSION SITE ERYTHEMA 1 0.0001
271 UTERINE PERFORATION 1 0.0001
272 VITAMIN D DECREASED 1 0.0001
273 DRUG RESISTANCE 3 0.0001
274 PULMONARY EMBOLISM 11 0.0001
275 DRUG INTOLERANCE 11 0.0001
276 PURPURA 1 0.0001
277 DRUG ERUPTION 2 0.0001
278 FOREIGN BODY IN REPRODUCTIVE TRACT 1 0.0001
279 ANAL INCONTINENCE 1 0.0001
280 MOOD ALTERED 3 0.0001
281 IRON DEFICIENCY ANAEMIA 1 0.0001
282 CONJUNCTIVITIS 2 0.0001
283 HAEMOPTYSIS 3 0.0001
284 BLOOD CREATININE INCREASED 7 0.0001
285 SQUAMOUS CELL CARCINOMA 1 0.0001
286 DECREASED APPETITE 24 0.0001
287 HEPATIC ENZYME INCREASED 7 0.0001
288 PARKINSONISM 1 0.0001
289 VITAMIN D DEFICIENCY 1 0.0001
290 BODY TEMPERATURE DECREASED 1 0.0001
291 PYREXIA 35 0.0001
292 LIGAMENT SPRAIN 1 0.0001
293 SALIVARY HYPERSECRETION 1 0.0001
294 THERAPEUTIC RESPONSE DECREASED 6 0.0001
295 TASTE DISORDER 2 0.0001
296 SUBARACHNOID HAEMORRHAGE 1 0.0001
297 SUDDEN DEATH 1 0.0001
298 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
299 METABOLIC ACIDOSIS 3 0.0001
300 MUSCULOSKELETAL STIFFNESS 8 0.0001
301 TOOTH FRACTURE 1 0.0001
302 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
303 SKIN DISORDER 3 0.0001
304 GASTROINTESTINAL DISORDER 8 0.0001
305 INTESTINAL PERFORATION 1 0.0001
306 NEPHROPATHY TOXIC 1 0.0001
307 OFF LABEL USE 78 0.0001
308 PANCREATITIS ACUTE 2 0.0001
309 BLOOD CALCIUM DECREASED 1 0.0001
310 HEART RATE IRREGULAR 2 0.0001
311 DERMATITIS CONTACT 1 0.0001
312 SCAB 1 0.0001
313 CONVULSION 5 0.0001
314 NEPHROLITHIASIS 4 0.0001
315 DRY MOUTH 7 0.0001
316 ABDOMINAL DISTENSION 9 0.0001
317 MYOCLONUS 1 0.0001
318 RESPIRATORY DEPRESSION 1 0.0001
319 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
320 HYPERCALCAEMIA 1 0.0001
321 SECRETION DISCHARGE 1 0.0001
322 DERMATITIS ALLERGIC 1 0.0001
323 MUSCLE ATROPHY 1 0.0001
324 INJECTION SITE INDURATION 1 0.0001
325 SEDATION 2 0.0001
326 ADVERSE REACTION 1 0.0001
327 PERIPHERAL COLDNESS 1 0.0001
328 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
329 ASTHMA 8 0.0001
330 DIALYSIS 1 0.0001
331 HYPERSOMNIA 2 0.0001
332 URINARY INCONTINENCE 2 0.0001
333 IRRITABILITY 4 0.0001
334 BLOOD POTASSIUM DECREASED 2 0.0001
335 ACNE 5 0.0001
336 DEVICE FAILURE 1 0.0001
337 OEDEMA PERIPHERAL 8 0.0001
338 BASAL CELL CARCINOMA 1 0.0001
339 CYANOSIS 1 0.0001
340 RESPIRATORY TRACT CONGESTION 1 0.0001
341 ANAEMIA 12 0.0001
342 CYSTITIS 2 0.0001
343 CARDIAC FAILURE 5 0.0001
344 HYPOGLYCAEMIA 3 0.0001
345 CARDIAC ARREST 5 0.0001
346 VENTRICULAR TACHYCARDIA 1 0.0001
347 PRODUCT USE IN UNAPPROVED INDICATION 15 0.0001
348 CIRCULATORY COLLAPSE 1 0.0001
349 MUSCULOSKELETAL DISCOMFORT 1 0.0001
350 LOCAL SWELLING 1 0.0001
351 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
352 THIRST 1 0.0001
353 PNEUMONIA 18 0.0001
354 DRUG INEFFECTIVE 73 0.0001
355 COMPLICATION OF DEVICE REMOVAL 1 0.0001
356 OSTEOMYELITIS 1 0.0001
357 TREMOR 9 0.0001
358 MIDDLE INSOMNIA 1 0.0001
359 FRACTURE 1 0.0001
360 CONDITION AGGRAVATED 16 0.0001
361 SLEEP APNOEA SYNDROME 1 0.0001
362 INCREASED APPETITE 1 0.0001
363 LETHARGY 3 0.0001
364 SURGERY 3 0.0001
365 PRODUCT DOSE OMISSION ISSUE 15 0.0001
366 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
367 PLEURAL EFFUSION 3 0.0000
368 DYSKINESIA 2 0.0000
369 BODY TEMPERATURE INCREASED 1 0.0000
370 OSTEOPOROSIS 2 0.0000
371 PULMONARY HYPERTENSION 1 0.0000
372 WEIGHT DECREASED 13 0.0000
373 SKIN CANCER 1 0.0000
374 CONSTIPATION 10 0.0000
375 MELAENA 1 0.0000
376 GLOSSODYNIA 1 0.0000
377 THERAPY NON-RESPONDER 2 0.0000
378 SHOCK 1 0.0000
379 PERICARDIAL EFFUSION 1 0.0000
380 COGNITIVE DISORDER 2 0.0000
381 HYPERTENSION 9 0.0000
382 MIGRAINE 4 0.0000
383 BLOOD PRESSURE FLUCTUATION 1 0.0000
384 AGITATION 3 0.0000
385 EPISTAXIS 3 0.0000
386 FATIGUE 30 0.0000
387 RESPIRATORY TRACT INFECTION 1 0.0000
388 EAR INFECTION 1 0.0000
389 PLATELET COUNT DECREASED 4 0.0000
390 JAUNDICE 1 0.0000
391 PALLOR 1 0.0000
392 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
393 MENTAL STATUS CHANGES 1 0.0000
394 WOUND 1 0.0000
395 WEIGHT INCREASED 8 0.0000
396 OXYGEN SATURATION DECREASED 2 0.0000
397 INTENTIONAL DOSE OMISSION 1 0.0000
398 RED BLOOD CELL COUNT DECREASED 1 0.0000
399 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
400 ASTHENIA 13 0.0000
401 ABDOMINAL PAIN UPPER 7 0.0000
402 LABORATORY TEST ABNORMAL 1 0.0000
403 DISEASE PROGRESSION 4 0.0000
404 WHEEZING 2 0.0000
405 RESPIRATORY DISORDER 1 0.0000
406 HEPATIC FAILURE 1 0.0000
407 LIMB DISCOMFORT 1 0.0000
408 FEMUR FRACTURE 1 0.0000
409 MOVEMENT DISORDER 1 0.0000
410 DIARRHOEA 20 0.0000
411 DYSPEPSIA 3 0.0000
412 EYE DISORDER 1 0.0000
413 HEART RATE INCREASED 3 0.0000
414 ABDOMINAL PAIN 7 0.0000
415 DEHYDRATION 4 0.0000
416 URINARY RETENTION 1 0.0000
417 GAIT INABILITY 1 0.0000
418 VOMITING 14 0.0000
419 TOXICITY TO VARIOUS AGENTS 5 0.0000
420 ANGER 1 0.0000
421 FLUSHING 3 0.0000
422 URINARY TRACT INFECTION 5 0.0000
423 HEART RATE DECREASED 1 0.0000
424 DIZZINESS 14 0.0000
425 INFECTION 4 0.0000
426 NO ADVERSE EVENT 5 0.0000
427 DRUG EFFECT INCOMPLETE 1 0.0000
428 CRYING 1 0.0000
429 RESTLESSNESS 1 0.0000
430 BRONCHITIS 2 0.0000
431 DYSGEUSIA 2 0.0000
432 PRODUCT USE ISSUE 5 0.0000
433 DYSARTHRIA 1 0.0000
434 MUSCULAR WEAKNESS 3 0.0000
435 COLITIS 1 0.0000
436 DEPRESSION 6 0.0000
437 GAIT DISTURBANCE 5 0.0000
438 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
439 DEVICE BREAKAGE 1 0.0000
440 BLINDNESS 1 0.0000
441 TREATMENT FAILURE 2 0.0000
442 POLLAKIURIA 1 0.0000
443 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
444 CARDIO-RESPIRATORY ARREST 1 0.0000
445 ROAD TRAFFIC ACCIDENT 1 0.0000
446 DEVICE LEAKAGE 1 0.0000
447 VAGINAL HAEMORRHAGE 1 0.0000
448 RENAL FAILURE 3 0.0000
449 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
450 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
451 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
452 NEUROPATHY PERIPHERAL 2 0.0000
453 MULTIPLE SCLEROSIS 1 0.0000
454 DEATH 18 0.0000
455 BLOOD GLUCOSE DECREASED 1 0.0000
456 CELLULITIS 1 0.0000
457 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
458 BLOOD PRESSURE INCREASED 3 0.0000
459 THERAPY CESSATION 1 0.0000
460 NERVOUSNESS 1 0.0000
461 MUSCULOSKELETAL PAIN 1 0.0000
462 SPEECH DISORDER 1 0.0000
463 PANCREATITIS 1 0.0000
464 BRADYCARDIA 1 0.0000
465 DISTURBANCE IN ATTENTION 1 0.0000
466 INFLUENZA 2 0.0000
467 THROMBOCYTOPENIA 2 0.0000
468 FLATULENCE 1 0.0000
469 HEADACHE 11 0.0000
470 PRODUCT SUBSTITUTION ISSUE 1 0.0000
471 DYSPHONIA 1 0.0000
472 BONE PAIN 1 0.0000
473 NASAL CONGESTION 1 0.0000
474 SUICIDE ATTEMPT 1 0.0000
475 STOMATITIS 1 0.0000
476 PAIN 10 0.0000
477 INTENTIONAL OVERDOSE 1 0.0000
478 RHINORRHOEA 1 0.0000
479 NAUSEA 12 0.0000
480 BLOOD PRESSURE DECREASED 1 0.0000
481 FALL 5 0.0000
482 INSOMNIA 4 0.0000
483 NEOPLASM MALIGNANT 1 0.0000
484 INJECTION SITE PRURITUS 1 0.0000
485 INJECTION SITE REACTION 1 0.0000
486 COUGH 4 0.0000
487 BURNING SENSATION 1 0.0000
488 INJURY 1 0.0000
489 PAIN IN EXTREMITY 4 0.0000
490 HYPOAESTHESIA 2 0.0000
491 HALLUCINATION 1 0.0000
492 UNEVALUABLE EVENT 1 0.0000
493 BACK PAIN 3 0.0000
494 INJECTION SITE BRUISING 1 0.0000
495 CONFUSIONAL STATE 2 0.0000
496 ABDOMINAL DISCOMFORT 2 0.0000
497 BALANCE DISORDER 1 0.0000
498 RASH 5 0.0000
499 MYOCARDIAL INFARCTION 2 0.0000
500 TACHYCARDIA 1 0.0000
501 NASOPHARYNGITIS 2 0.0000
502 OROPHARYNGEAL PAIN 1 0.0000
503 DYSPNOEA 6 0.0000
504 ANXIETY 3 0.0000
505 ATRIAL FIBRILLATION 1 0.0000
506 ALOPECIA 2 0.0000
507 SINUSITIS 1 0.0000
508 ERYTHEMA 2 0.0000
509 ILLNESS 1 0.0000
510 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
511 CHILLS 1 0.0000
512 FEELING ABNORMAL 2 0.0000
513 JOINT SWELLING 1 0.0000
514 INJECTION SITE ERYTHEMA 1 0.0000
515 LOSS OF CONSCIOUSNESS 1 0.0000
516 MEMORY IMPAIRMENT 1 0.0000
517 HOSPITALISATION 1 0.0000
518 PERIPHERAL SWELLING 1 0.0000
519 PARAESTHESIA 1 0.0000
520 URTICARIA 1 0.0000
521 MUSCLE SPASMS 1 0.0000
522 HYPERSENSITIVITY 1 0.0000
523 OVERDOSE 1 0.0000
524 MALAISE 2 0.0000
525 INJECTION SITE PAIN 1 0.0000